According to a consensus statement developed by the American Cancer Society, the Gynecologic Cancer Foundation, and the Society of Gynecologic Oncologists, certain symptoms are more likely to occur in women with ovarian cancer than women in the general population. Women who experience these symptoms are encouraged to discuss them with a physician, preferably a gynecologist.
Among U.S. women ovarian cancer is the fifth most common cause of cancer death. It results in more than 15,000 deaths each year.[](http://news.cancerconnect.com/women-encouraged-to-watch-for-ovarian-cancer-warning-signs/#_edn1 "_ednref1")
A factor that contributes to many of these deaths is the tendency of ovarian cancer to be diagnosed at an advanced stage. Although screening tests such as mammography for breast cancer and the Pap test for cervical cancer have improved the early detection of those diseases, there are no comparable screening tests for ovarian cancer.
Alerting women to potential symptoms of ovarian cancer may be a partial solution to this problem. Although the ultimate screening goal is to identify ovarian cancer at its earliest stages-before it even produces symptoms-prompt evaluation of symptoms is likely to allow some women to be diagnosed earlier than they would have been otherwise.
Based on previous research, a group of cancer organizations developed a set of symptoms that should alert women to the possibility of ovarian cancer. These symptoms include the following:
- Pelvic or abdominal pain
- Difficulty eating or feeling full quickly
- Urinary symptoms (urgency or frequency)
Although these symptoms can be caused by conditions other than ovarian cancer, women who experience these symptoms almost daily for more than a few weeks are encouraged to see a doctor, preferably a gynecologist.[](http://news.cancerconnect.com/women-encouraged-to-watch-for-ovarian-cancer-warning-signs/#_edn2 "_ednref2")
Tisotumab Vedotin – Promising in Advanced Cervical Cancer
Novel precision cancer medicine promising for treatment of advanced ovarian cancer.
Checkpoint Inhibitor Immunotherapy for Treatment of Advanced Cervical Cancer
Checkpoint inhibitor immunotherapy prolongs survival and delays recurrence in advanced cervical cancer.
Precision Antibody-drug conjugate promising in Ovarian Cancer
Learn about the STRO-002 Antibody-drug conjugate in Ovarian Cancer
[](http://news.cancerconnect.com/women-encouraged-to-watch-for-ovarian-cancer-warning-signs/#_ednref1 "_edn1") American Cancer Society. Cancer Facts & Figures 2007. Available at: http://www.cancer.org/docroot/stt/stt_0.asp (Accessed June 20, 2007).
[](http://news.cancerconnect.com/women-encouraged-to-watch-for-ovarian-cancer-warning-signs/#_ednref2 "_edn2") American Cancer Society. Ovarian cancer has early symptoms. First national consensus on common warning signs. Available at: http://www.cancer.org/docroot/NWS/content/NWS_1_1x_Ovarian_Cancer_Symptoms_The_Silence_Is_Broken.asp (Accessed June 20, 2007).
Related News:Postmenopausal Hormones Linked with Increased Risk of Ovarian Cancer (05/21/2007)
Copyright © 2018 CancerConnect. All Rights Reserved.